Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1998-9-10
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0934-8387
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
52
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
358-65
|
| pubmed:dateRevised |
2009-4-7
|
| pubmed:meshHeading | |
| pubmed:year |
1998
|
| pubmed:articleTitle |
[Ozone--position of the the Advisory Commission of the Toxicology Section of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT)].
|
| pubmed:affiliation |
Humboldt-Universität Virchow-Klinikum Klinik für Dermatologie, Berlin.
|
| pubmed:publicationType |
Journal Article,
Guideline,
Review
|